The FDAs proposed change signals a potential shift toward tighter regulation of compounded versions as availability of commercial products improves
Contact your GP for persistent worsening symptoms, new neurological problems, irregular heartbeat, or concerns about your response to treatment
Hear why so many people love our MAPS programs
GLP-1 receptor agonists, such as liraglutide, exenatide, and semaglutide, originally developed for type 2 diabetes (T2DM) management, show promise in improving psoriasis symptoms by reducing inflammation and addressing metabolic issues
If you are pregnant, breastfeeding or taking any medication, consult your doctor before use
JACC: Basic to Translational Science